Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats
Introduction
Repeated administration of psychostimulants (e.g. cocaine, amphetamine) results in a progressive augmentation of their stimulatory effects, a phenomenon referred to as sensitization (Kalivas and Stewart, 1991). This phenomenon, which can persist for weeks or months following the cessation of drug treatment, has been implicated in drug-craving and reinstatement of compulsive drug-seeking behavior (Robinson and Berridge, 1993). Rewarding effect of drug is thought to be associated with a feeling of “euphoria” that may also lead to compulsive drug-seeking and taking in humans. Conditioned place preference paradigm is an animal model for evaluation of the reward produced by drugs of abuse Tzschentke, 1998, Schechter and Calcagnetti, 1993, Schechter and Calcagnetti, 1998, Carr et al., 1989. Both these animal models underlay many aspects of drug addiction and craving in humans.
The rewarding and psychomotor-stimulating effects of cocaine and amphetamine seem to be associated with the increase in dopaminergic and glutamatergic transmission in mesolimbic corticostriatal pathways Wolf, 1998, Pierce and Kalivas, 1997. These neurotransmitters are also involved in the development of increased sensitivity to psychostimulants after repeated exposure to the drug (e.g. behavioral sensitization) Karler et al., 1994, Karler et al., 1995.
Our previous studies have demonstrated a suppressive effect of centrally administered nociceptin, the natural ligand of the G-protein-coupled NOP receptor on the expression of cocaine-induced conditioned place preference in rats (Kotlinska et al., 2002). Nociceptin, despite the structural similarity with dynorphin A Meunier et al., 1995, Reinscheid et al., 1995, does not bind to the opioid receptors, and its pharmacological effects are not sensitive to naloxone treatment (Jenck et al., 2000). However, in contrast to opioids, nociceptin elicits hyperalgesia rather than analgesia when administered at a supraspinal site and, furthermore, it affects feeding, learning, and memory, anxiety, and vegetative functions (for review, see Mogil and Pasternak, 2001). One aspect in which the classical opioid and NOP receptors resemble each other is that they occur presynaptically on a variety of neurons where they cause inhibition of release of a respective neurotransmitter (Schlicker and Morari, 2000).
The NOP receptors (Mollereau et al., 1994) and nociceptin-like immunoreactivity are widely distributed in the brain Anton et al., 1996, Peluso et al., 1998, particularly in areas involved in motivational and emotional behaviors. Unlike opioid peptides, nociceptin does not produce a conditioned place preference or aversion (Devine et al., 1996a) but inhibits rewarding effect of drugs of abuse Ciccocioppo et al., 2000a, Ciccocioppo et al., 2000b. The aim of present study was to investigate the influence of nociceptin on the acquisition of amphetamine-induced place preference and the acquisition of amphetamine-induced sensitization to stereotypy in rats.
Section snippets
Subjects and surgery
Male Wistar rats (220–250 g, Gorzkowska, Warszawa, Poland) were chosen as the strain sensitive to rewarding effects of drugs (Bardo et al., 1995). The animals were housed six per cage with standard food (Bacutil-Motycz, Poland) and water ad libitum. The animals were kept under a 12:12-h light–dark cycle and were adapted to the laboratory conditions for at least 1 week. The rats were handled once a day for 5 days before the beginning of the experiment. At least 5 days before the experiments, the
Effect of nociceptin on the acquisition of conditioned place preference induced by amphetamine
On the pre-conditioning test day, the rats spent significantly more time in the black compartment (>480 s) than in the white compartment (<60 s). The side preference was not statistically different between groups. The natural preferences of rats were not changed by saline injection during conditioning sessions.
The data were expressed as a score, i.e. testing minus pre-testing time (in seconds) spent in a drug-associated (white) compartment. One-way ANOVA revealed significant differences between
Discussion
The main finding of the present study is that the increasing doses of nociceptin given i.c.v. prior to systemic amphetamine administration during conditioned phase of place preference paradigm block the acquisition of amphetamine-induced place preference. Furthermore, chronic injection of nociceptin at the increasing doses, prior to the amphetamine injection, blocks amphetamine sensitization to stereotypy. Single injection of nociceptin (i.e. 5 nmol) does not change the acute
Acknowledgments
This work was supported by the grant from the Medical Academy (DS 23/02) and a grant from the Polish Committee for Scientific Research (KBN 3P04B02024).
References (57)
- et al.
Effect of MS-153 on the development of behavioral sensitization to stereotypy-induced effect of phencyclidine
Brain Res.
(2002) - et al.
Conditioned place preference using opiate and stimulant drugs: a meta-analysis
Neurosci. Biobehav. Rev.
(1995) - et al.
The role of the striatum in the mouse in behavioral sensitization to amphetamine
Pharmacol. Biochem. Behav.
(1997) - et al.
Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine
Eur. J. Pharmacol.
(1994) - et al.
Nociceptin/orphanin FQ and drugs of abuse
Peptides
(2000) - et al.
Effect of nociceptin/orphanin FQ on the rewarding properties of morphine
Eur. J. Pharmacol.
(2000) - et al.
Substantia nigra and stereotyped behavior
Eur. J. Pharmacol.
(1972) - et al.
The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion
Brain Res.
(1996) - et al.
Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats
Neurosci. Lett.
(1999) - et al.
A dopaminergic–glutamatergic basis for the action of amphetamine and cocaine
Brain Res.
(1994)
The dopaminergic, glutaminergic, GABAergic bases for the action of amphetamine and cocaine
Brain Res.
ORL1, a novel member of the opioid receptor family-cloning, functional expression and localization
FEBS Lett.
Orphanin FQ/nociceptin blocks acquisition of morphine place preference
Brain Res.
Role of nociceptin systems in learning and memory
Peptides
Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells
J. Neuroimmunol.
A circuity model of the expression of behavioral sensitization of amphetamine-like psychostimulants
Brain Res. Rev.
Peripheral electric stimulation attenuates the express of cocaine-induced place preference in rats
Brain Res.
The neural basis of drug craving: an incentive-sensitization theory of addiction
Brain Res. Rev.
Trends in place preference conditioning with a cross-indexed bibliography; 1957–1991
Neurosci. Biobehav. Rev.
Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography
Neurosci. Biobehav. Rev.
Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system
Peptides
Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration
Pharmacol. Biochem. Behav.
Dopaminergic substrates of amphetamine-induced place preference conditioning
Brain Res.
Measuring reward with the conditioned place preference paradigm: a comprehensive review of drugs, recent progress and new issues
Prog. Neurobiol.
Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole
Neurosci. Lett.
Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects
Brain Res.
The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
Prog. Neurobiol.
Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice
Pharmacol. Biochem. Behav.
Cited by (59)
Hot topics in opioid pharmacology: mixed and biased opioids
2019, British Journal of AnaesthesiaThe Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction
2016, Progress in Molecular Biology and Translational ScienceThe biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence
2014, Pharmacology and TherapeuticsCitation Excerpt :Additional studies with psychostimulants investigated the ability of NOP agonism to prevent the development or the expression of sensitization to cocaine and methamphetamine. Results revealed that N/OFQ blocked cocaine- and amphetamine-induced psychomotor sensitization (Lutfy et al., 2002; Kotlinska et al., 2003; Bebawy et al., 2011), an effect that was absent in NOP receptor KO mice (Bebawy et al., 2011). Prior to drawing definitive conclusions on the potential of NOP agonists in psychostimulant addiction, their ability to prevent operant drug self-administration and reinstatement should be explored.